Binding of plasminogen activators to fibrin: characterization and pharmacological consequences
- 15 July 1989
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 261 (2) , 313-324
- https://doi.org/10.1042/bj2610313
Abstract
No abstract availableThis publication has 85 references indexed in Scilit:
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988
- The FDA Advisory Panel's Decision on rt‐PAThe Journal of Clinical Pharmacology, 1987
- Thrombospondin-Plasminogen Interactions: Modulation of Plasmin GenerationSeminars in Thrombosis and Hemostasis, 1987
- Covalent molecular weight .apprx. 92,000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domainsBiochemistry, 1986
- Fibrin and plasminogen structures essential to stimulation of plasmin formation by tissue-type plasminogen activatorBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986
- Thrombolysis, clot selectivity, and kinetics.Circulation, 1984
- Identification of a site in fibrin(OGEN) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activatorBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1983
- Systemic thrombolytic therapy of acute myocardial infarction?Circulation, 1983
- Morphology of bovine fibrinogen monomers and fibrin oligomersJournal of Molecular Biology, 1981
- The Effectiveness of Activators in Clot Lysis, with Special Reference to Fibrinolytic Therapy: A New Method for Determination of Preformed Clot LysisActa Medica Scandinavica, 1962